New clotting drug shows promise for rare bleeding disorder in chinese adults
NCT ID NCT07129343
First seen Jan 09, 2026 · Last updated May 12, 2026 · Updated 24 times
Summary
This study tests a drug called VONVENDI (recombinant von Willebrand factor) to see if it is safe and helps control bleeding in Chinese adults with von Willebrand disease (VWD), a condition that makes blood clot poorly. About 20 participants will receive the drug, sometimes with another clotting factor (ADVATE), before surgeries or dental procedures. The study lasts about 14 months and monitors side effects, bleeding control, and how the body processes the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
RECRUITINGTianjin, 300052, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jinan Central Hospital
RECRUITINGJihan, 250013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nanfang Hospital Southern Medical University
RECRUITINGGuangzhou, 510515, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking Union Medical College Hospital
RECRUITINGBeijing, 100006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ruijin Hospital Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, 201801, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, 215005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, 430032, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.